Cargando…
Formulation of Levocetirizine-Loaded Core–Shell Type Nanofibrous Orally Dissolving Webs as a Potential Alternative for Immediate Release Dosage Forms
Several applications of nanofiber-based systems are based on their corresponding functionality-related properties, which often cannot be satisfied by a fiber web with a monolithic structure because of the various physicochemical properties and amounts of embedded compounds. Therefore, one of the mai...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317969/ https://www.ncbi.nlm.nih.gov/pubmed/35890336 http://dx.doi.org/10.3390/pharmaceutics14071442 |
_version_ | 1784755183981428736 |
---|---|
author | Kazsoki, Adrienn Palcsó, Barnabás Omer, Safaa Mohammed Kovacs, Zoltan Zelkó, Romána |
author_facet | Kazsoki, Adrienn Palcsó, Barnabás Omer, Safaa Mohammed Kovacs, Zoltan Zelkó, Romána |
author_sort | Kazsoki, Adrienn |
collection | PubMed |
description | Several applications of nanofiber-based systems are based on their corresponding functionality-related properties, which often cannot be satisfied by a fiber web with a monolithic structure because of the various physicochemical properties and amounts of embedded compounds. Therefore, one of the main directions in the development of fiber systems is creating core–shell type complex fiber structures that can provide application-specific properties to the fiber matrix. The present study aimed to formulate levocetirizine-loaded core–shell type hydrophilic polymer-based fibrous systems. The core phase contained the antihistamine levocetirizine, while the permeation enhancer (Na-taurocholate), the local pH regulator (citric acid), and the cyclodextrin used as a taste masking agent were included in the shell phase of the fibrous formulation. Scanning electron microscopy images indicated that a randomly oriented homogeneous fibrous structure was obtained, while the Raman mapping and chemometric analysis confirmed the partially formed core–shell structure. A fast release rate of the antihistamine drug from the complex structural fibrous system was obtained (within 1 min complete dissolution can be observed) due to its increased surface area to volume ratio and its more favorable wettability properties, which consequently allows for more erosion. The masking properties against the unpleasant bitter taste of API of the formulated complex nanostructure were confirmed by the results of the electronic tongue. The formulated complex nanostructure enabled fast and complete release of the API, providing a potential enhancement in the rate and extent of absorption while masking the unpleasant taste of levocetirizine, which has a high impact on the patient adherence. All in all, the results show that the developed orally dissolving fibrous web formulation can be a potential alternative to the commercially available orally disintegrating tablets. |
format | Online Article Text |
id | pubmed-9317969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93179692022-07-27 Formulation of Levocetirizine-Loaded Core–Shell Type Nanofibrous Orally Dissolving Webs as a Potential Alternative for Immediate Release Dosage Forms Kazsoki, Adrienn Palcsó, Barnabás Omer, Safaa Mohammed Kovacs, Zoltan Zelkó, Romána Pharmaceutics Article Several applications of nanofiber-based systems are based on their corresponding functionality-related properties, which often cannot be satisfied by a fiber web with a monolithic structure because of the various physicochemical properties and amounts of embedded compounds. Therefore, one of the main directions in the development of fiber systems is creating core–shell type complex fiber structures that can provide application-specific properties to the fiber matrix. The present study aimed to formulate levocetirizine-loaded core–shell type hydrophilic polymer-based fibrous systems. The core phase contained the antihistamine levocetirizine, while the permeation enhancer (Na-taurocholate), the local pH regulator (citric acid), and the cyclodextrin used as a taste masking agent were included in the shell phase of the fibrous formulation. Scanning electron microscopy images indicated that a randomly oriented homogeneous fibrous structure was obtained, while the Raman mapping and chemometric analysis confirmed the partially formed core–shell structure. A fast release rate of the antihistamine drug from the complex structural fibrous system was obtained (within 1 min complete dissolution can be observed) due to its increased surface area to volume ratio and its more favorable wettability properties, which consequently allows for more erosion. The masking properties against the unpleasant bitter taste of API of the formulated complex nanostructure were confirmed by the results of the electronic tongue. The formulated complex nanostructure enabled fast and complete release of the API, providing a potential enhancement in the rate and extent of absorption while masking the unpleasant taste of levocetirizine, which has a high impact on the patient adherence. All in all, the results show that the developed orally dissolving fibrous web formulation can be a potential alternative to the commercially available orally disintegrating tablets. MDPI 2022-07-11 /pmc/articles/PMC9317969/ /pubmed/35890336 http://dx.doi.org/10.3390/pharmaceutics14071442 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kazsoki, Adrienn Palcsó, Barnabás Omer, Safaa Mohammed Kovacs, Zoltan Zelkó, Romána Formulation of Levocetirizine-Loaded Core–Shell Type Nanofibrous Orally Dissolving Webs as a Potential Alternative for Immediate Release Dosage Forms |
title | Formulation of Levocetirizine-Loaded Core–Shell Type Nanofibrous Orally Dissolving Webs as a Potential Alternative for Immediate Release Dosage Forms |
title_full | Formulation of Levocetirizine-Loaded Core–Shell Type Nanofibrous Orally Dissolving Webs as a Potential Alternative for Immediate Release Dosage Forms |
title_fullStr | Formulation of Levocetirizine-Loaded Core–Shell Type Nanofibrous Orally Dissolving Webs as a Potential Alternative for Immediate Release Dosage Forms |
title_full_unstemmed | Formulation of Levocetirizine-Loaded Core–Shell Type Nanofibrous Orally Dissolving Webs as a Potential Alternative for Immediate Release Dosage Forms |
title_short | Formulation of Levocetirizine-Loaded Core–Shell Type Nanofibrous Orally Dissolving Webs as a Potential Alternative for Immediate Release Dosage Forms |
title_sort | formulation of levocetirizine-loaded core–shell type nanofibrous orally dissolving webs as a potential alternative for immediate release dosage forms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317969/ https://www.ncbi.nlm.nih.gov/pubmed/35890336 http://dx.doi.org/10.3390/pharmaceutics14071442 |
work_keys_str_mv | AT kazsokiadrienn formulationoflevocetirizineloadedcoreshelltypenanofibrousorallydissolvingwebsasapotentialalternativeforimmediatereleasedosageforms AT palcsobarnabas formulationoflevocetirizineloadedcoreshelltypenanofibrousorallydissolvingwebsasapotentialalternativeforimmediatereleasedosageforms AT omersafaamohammed formulationoflevocetirizineloadedcoreshelltypenanofibrousorallydissolvingwebsasapotentialalternativeforimmediatereleasedosageforms AT kovacszoltan formulationoflevocetirizineloadedcoreshelltypenanofibrousorallydissolvingwebsasapotentialalternativeforimmediatereleasedosageforms AT zelkoromana formulationoflevocetirizineloadedcoreshelltypenanofibrousorallydissolvingwebsasapotentialalternativeforimmediatereleasedosageforms |